PathoCare
Houston
About PathoCare
Developer of a Spectroscopy-based testing platform designed to provide rapid, non-invasive, and cost-effective diagnostic tests for respiratory infections. The company platform offers mobile, accurate, and reusable point-of-care testing devices with adaptive artificial intelligence, enabling healthcare providers to diagnose respiratory infections more efficiently and reduce reliance on traditional chemical-based processes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Total funding: $150.2M
- Last round: Series Unknown (Dec 2024)
Industries & Categories
Health Care, Health Diagnostics, Machine Learning
Canonical: https://fsome.com/organization/pathocare-39655 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.